These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7986113)

  • 1. [Current status of clinical trials on pre- and postoperative chemotherapy for head and neck cancer].
    Inuyama Y; Fukuda S; Horiuchi M
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():338-47. PubMed ID: 7986113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Head and neck cancer].
    Inuyama Y; Fukuda S; Fujii M
    Gan To Kagaku Ryoho; 1995 May; 22(6):732-8. PubMed ID: 7755381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of platinum chemotherapy in head and neck cancer.
    Forastiere AA
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):20-7. PubMed ID: 7527591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future chemotherapy and radiotherapy options in head and neck cancer.
    Merlano M; Mattiot VP
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):395-403. PubMed ID: 16503856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].
    Horiuchi M; Tamura Y; Miyake H
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):417-24. PubMed ID: 8129381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of Chemotherapy in head and neck cancer].
    Kohno N; Kitahara S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck].
    Taguchi T; Tsukuda M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multidisciplinary treatment for organ/function preservation in head and neck cancer].
    Inuyama Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):396-402. PubMed ID: 7927168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin combinations in the treatment of head and neck cancer.
    al-Sarraf M
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):28-34. PubMed ID: 7992064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?
    Bernier J; Cooper JS
    Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant chemotherapy of head and neck cancer].
    Fujii M; Kawasaki K
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2083-9. PubMed ID: 1716091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
    Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
    Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging standards of concomitant chemoradiotherapy.
    Adelstein DJ; Rodriguez CP
    Semin Oncol; 2008 Jun; 35(3):211-20. PubMed ID: 18544436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in the treatment of head and neck tumors. I. Chemotherapy].
    Stupp R; Vokes EE
    Strahlenther Onkol; 1995 Jan; 171(1):12-7. PubMed ID: 7839300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.